Jefferies Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Jefferies Group’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13,500	Closed	-$43.6K	–	2090
2021 Q1	$43.6K	Buy	+13,500	New	+$45K	﹤0.01%	1519
2015 Q3	–	Sell	-268	Closed	-$3K	–	3218
2015 Q2	$3K	Buy	+268	New	+$3.44K	﹤0.01%	3109
2015 Q1	–	Sell	-13,804	Closed	-$233K	–	2468
2014 Q4	$233K	Buy	+13,804	New	+$201K	﹤0.01%	1676
2014 Q1	–	Sell	-95	Closed	-$1K	–	2453
2013 Q4	$1K	Sell	95 -54,426	-100%	-$769K	﹤0.01%	1866
2013 Q3	$950K	Buy	54,521 +53,736	+6,845%	+$1.03M	0.01%	930
2013 Q2	$13K	Buy	+785	New	+$24.3K	﹤0.01%	1752

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

GPC

Guardian Point Capital Charlottesville, Virginia $243M AUM 22.43% 1-Year Est. Return

Jefferies Group's INFI Position: Q2 2021 in Review

Jefferies Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2021, closing a stake of 13,500 shares — an estimated $43.6K sold.

Jefferies Group first reported a position in INFI in Q2 2013 and held it in 6 quarters. The position peaked at $950K in Q3 2013. 97 funds tracked by Wall St. Rank hold INFI as of Q2 2021.

Jefferies Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
Jefferies Group sold 13,500 Infinity Pharmaceuticals, Inc. shares in Q2 2021, an estimated $43.6K.
Jefferies Group first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 6 quarters.
Jefferies Group's Infinity Pharmaceuticals, Inc. position peaked at $950K in Q3 2013.
97 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2021.

Based on Jefferies Group's 13F filing for Q2 2021, filed 16 Aug 2021.